These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury. Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604 [TBL] [Abstract][Full Text] [Related]
23. TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration. Liu S; Wang L; Wang W; Lin J; Han J; Sun H; Guo H; Sun R; Wu Q Exp Mol Pathol; 2006 Apr; 80(2):132-40. PubMed ID: 16256108 [TBL] [Abstract][Full Text] [Related]
24. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725 [TBL] [Abstract][Full Text] [Related]
25. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Zhang Y; He X; Chen X; Ma H; Liu D; Luo J; Du Z; Jin Y; Xiong Y; He J; Fang D; Wang K; Lawson WE; Hui JC; Zheng Z; Wu G Circulation; 2007 Jul; 116(5):526-34. PubMed ID: 17620513 [TBL] [Abstract][Full Text] [Related]
26. Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation. Cook JL; Mills SJ; Naquin R; Alam J; Re RN J Mol Cell Cardiol; 2006 May; 40(5):696-707. PubMed ID: 16516913 [TBL] [Abstract][Full Text] [Related]
27. Bilirubin inhibits tumor cell growth via activation of ERK. Ollinger R; Kogler P; Troppmair J; Hermann M; Wurm M; Drasche A; Königsrainer I; Amberger A; Weiss H; Ofner D; Bach FH; Margreiter R Cell Cycle; 2007 Dec; 6(24):3078-85. PubMed ID: 18073533 [TBL] [Abstract][Full Text] [Related]
28. The biliverdin-bilirubin antioxidant cycle of cellular protection: Missing a wheel? McDonagh AF Free Radic Biol Med; 2010 Sep; 49(5):814-20. PubMed ID: 20547221 [TBL] [Abstract][Full Text] [Related]
29. The impact of intestinal microflora on serum bilirubin levels. Vítek L; Zelenka J; Zadinová M; Malina J J Hepatol; 2005 Feb; 42(2):238-43. PubMed ID: 15664250 [TBL] [Abstract][Full Text] [Related]
30. The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. Wu TW; Carey D; Wu J; Sugiyama H Biochem Cell Biol; 1991 Dec; 69(12):828-34. PubMed ID: 1818587 [TBL] [Abstract][Full Text] [Related]
31. Effects of serum bilirubin on atherosclerotic processes. Kang SJ; Lee C; Kruzliak P Ann Med; 2014 May; 46(3):138-47. PubMed ID: 24720602 [TBL] [Abstract][Full Text] [Related]
32. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Peyton KJ; Shebib AR; Azam MA; Liu XM; Tulis DA; Durante W Front Pharmacol; 2012; 3():48. PubMed ID: 22470341 [TBL] [Abstract][Full Text] [Related]
33. Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure. Boon AC; Lam AK; Gopalan V; Benzie IF; Briskey D; Coombes JS; Fassett RG; Bulmer AC Sci Rep; 2015 Oct; 5():15482. PubMed ID: 26498893 [TBL] [Abstract][Full Text] [Related]
34. Bilirubin is produced nonenzymatically in plants to maintain chloroplast redox status. Ishikawa K; Xie X; Osaki Y; Miyawaki A; Numata K; Kodama Y Sci Adv; 2023 Jun; 9(23):eadh4787. PubMed ID: 37285441 [TBL] [Abstract][Full Text] [Related]
35. Bilirubin and the risk of common non-hepatic diseases. Rigato I; Ostrow JD; Tiribelli C Trends Mol Med; 2005 Jun; 11(6):277-83. PubMed ID: 15949769 [TBL] [Abstract][Full Text] [Related]
36. Biliverdin initiates the liver regeneration in the rat--a hypothesis. Okazaki K; Nishimura H; Arizono H; Nishimura N; Suzuki Y Biochem Biophys Res Commun; 1978 Mar; 81(2):512-20. PubMed ID: 666770 [No Abstract] [Full Text] [Related]
37. Enhancement of DNA synthesis by biliverdin in a non-transformed liver cell strain. Lafarge-Frayssinet C; Morel-Chany E; Trincal G; Frayssinet C Cell Mol Biol Incl Cyto Enzymol; 1981; 27(2-3):77-82. PubMed ID: 6271402 [No Abstract] [Full Text] [Related]
38. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Vítek L; Schwertner HA Adv Clin Chem; 2007; 43():1-57. PubMed ID: 17249379 [TBL] [Abstract][Full Text] [Related]
39. [Cytoprotective effects of bilirubin]. Vítek L Cas Lek Cesk; 2005; 144 Suppl 1():58-62. PubMed ID: 15981989 [TBL] [Abstract][Full Text] [Related]
40. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Jangi S; Otterbein L; Robson S Int J Biochem Cell Biol; 2013 Dec; 45(12):2843-51. PubMed ID: 24144577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]